Equities

Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)851.00
  • Today's Change1.00 / 0.12%
  • Shares traded40.92k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue41,78236,54836,719
OPERATING EXPENSES
Cost of revenue total27,43024,54924,881
Selling, general and admin. expenses, total8,9488,3677,284
Depreciation/amortization1,2561,128947
Unusual expense(income)252698130
Other operating expenses, total592633483
Total operating expense38,47835,37533,724
Operating income3,3041,1742,995
Other, net13928364
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(453)1,503(1932)
Provision for income taxes(461)525577
Net income after taxes7.90978(2509)
Minority interest(48)(30)(17)
Net income before extra. Items(40)949(2525)
Total extraordinary items------
Net income(40)949(2525)
Inc.avail. to common excl. extra. Items(40)949(2525)
Inc.avail. to common incl. extra. Items(40)949(2525)
EPS RECONCILIATION
Basic/primary weighted average shares157157157
Basic/primary eps excl. extra items(0.26)6.03(16)
Basic/primary eps incl. extra items(0.26)6.03(16)
Dilution adjustment------
Diluted weighted average shares157157157
Diluted eps excl. extra items(0.26)6.03(16)
Diluted eps incl. extra items(0.26)6.03(16)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue000
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental500452114
SUPPLEMENTAL INCOME
Depreciation, supplemental1,2341,110917
Total special items262677140
NORMALISED INCOME
Normalized income before taxes(191)2,180(1792)
Effect of special items on income taxes9223649
Income tax excluding impact of special items(369)761626
Normalized income after tax1781,419(2418)
Normalized income avail. to common1301,389(2434)
Basic normalized EPS0.838.83(15)
Diluted normalized EPS0.838.83(15)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.